Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.71%. A quarter ago, it was expected that this life-sciences research company would post a loss of $0.32 per share when it actually produced a loss of $0.30, delivering a surprise of 6.25%.Over the last four quar ...